Evidence map›Paper›PMID 40870493›Full record

ArticleMedicina (Kaunas, Lithuania)2025

The Role of Baseline PET/CT Parameters in Predicting Treatment Response in Patients with Locally Advanced Rectal Cancer Undergoing Total Neoadjuvant Therapy.

Ali Kaan Güren, Zilan Başkan, Zeynep Ceren Balaban Genç, Tuğçe Bulun Akyol, Erkam Kocaaslan, Yeşim Ağyol, Pınar Erel, Burak Paçacı, Mustafa Alperen Tunç, Ahmet Demirel and 10 more

Abstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Ali Kaan GürenDivision of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul 34854, Turkey.ORCID 0000-0002-3562-5006
Zilan BaşkanDepartment of Radiation Oncology, Marmara University School of Medicine, Istanbul 34854, Turkey.
Zeynep Ceren Balaban GençDepartment of Nuclear Medicine, Marmara University School of Medicine, Istanbul 34854, Turkey.
Tuğçe Bulun AkyolDepartment of Internal Medicine, Marmara University School of Medicine, Istanbul 34854, Turkey.
Erkam KocaaslanDivision of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul 34854, Turkey.
Yeşim AğyolDivision of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul 34854, Turkey.
Pınar ErelDivision of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul 34854, Turkey.
Burak PaçacıDivision of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul 34854, Turkey.
Mustafa Alperen TunçDivision of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul 34854, Turkey.ORCID 0000-0002-1537-3032
Ahmet DemirelDivision of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul 34854, Turkey.
Nargiz MajidovaDepartment of Medical Oncology, VM Medical Park Maltepe Hospital, Istanbul 34846, Turkey.ORCID 0000-0002-2575-5819
Nadiye SeverDivision of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul 34854, Turkey.ORCID 0000-0001-7312-3827
Abdussamet ÇelebiDivision of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul 34854, Turkey.
Selver IşıkDivision of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul 34854, Turkey.ORCID 0000-0002-2726-1740
Murat SarıDivision of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul 34854, Turkey.ORCID 0000-0003-0596-1559
Osman KöstekDivision of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul 34854, Turkey.
Salih ÖzgüvenDepartment of Nuclear Medicine, Marmara University School of Medicine, Istanbul 34854, Turkey.
Hilal AlkışDepartment of Radiation Oncology, Marmara University School of Medicine, Istanbul 34854, Turkey.
Mustafa AdliDepartment of Radiation Oncology, Marmara University School of Medicine, Istanbul 34854, Turkey.
İbrahim Vedat BayoğluDivision of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul 34854, Turkey.ORCID 0000-0002-0481-1084

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Neoadjuvant TherapyPositron Emission Tomography Computed TomographyRectal NeoplasmsAdultAgedCA-19-9 AntigenFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeCA-19-9 Antigencomplete responselocally advanced rectal cancermetabolic tumor volumetotal lesion glycolysistotal neoadjuvant therapy

Identifiers

PMID40870493
PMCPMC12388065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.